6,7-Dihydro-2,5-dimethyl-5H-cyclopentapyrazine
| Common Name: |
6,7-Dihydro-2,5-dimethyl-5H-cyclopentapyrazine |
| IUPAC Name: |
3,7-dimethyl-6,7-dihydro-5H-cyclopenta[b]pyrazine |
| Molecular Formula: |
C9H12N2 |
| SMILES: |
CC1CCC2=NC(=CN=C12)C |
| Inchi: |
1S/C9H12N2/c1-6-3-4-8-9(6)10-5-7(2)11-8/h5-6H,3-4H2,1-2H3 |
| Inchi Key: |
CTFGVWCFSGCLHZ-UHFFFAOYSA-N |
| Cas No: |
38917-61-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
148.20 |
| Mass (g/mol) |
148.1 |
| Molar Refractivity |
44.43 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
0 |
| Rings |
2 |
| TPSA |
25.78 |
| Hetero Atoms |
2 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
130 |
| Boiling Point (°C@760.00mm Hg) |
230.00 to 231.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.154 |
| Vapor Density (Air =1) |
5.1 |
| Fraction Csp3 |
0.56 |
| LogP |
1.835 |
| iLOGP |
1.99 |
| XLOGP3 |
1.23 |
| WLOGP |
1.83 |
| MLOGP |
0.87 |
| ESOL Log S |
-1.94 |
| ESOL Solubility (mg/ml) |
1.71 |
| ESOL Solubility (mol/l) |
0.012 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.37 |
| Ali Solubility (mg/ml) |
6.34 |
| Ali Solubility (mol/l) |
0.04 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-3.01 |
| Silicos-IT Solubility (mg/ml) |
0.15 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.33 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.613 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.342 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
1 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
